|
Volumn 42, Issue 12, 2001, Pages 2964-2969
|
Correction of early subnormal superior hemiretinal ΔPO2 predicts therapeutic efficacy in experimental diabetic retinopathy
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGUANIDINE;
CARBOGEN;
GALACTOSE;
GLUCOSE;
UNCLASSIFIED DRUG;
WAY 509;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BLOOD OXYGENATION;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC RETINOPATHY;
DIAGNOSTIC ACCURACY;
DRUG EFFICACY;
GALACTOSEMIA;
GLUCOSE BLOOD LEVEL;
HYPEROXIA;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OXYGEN TENSION;
PRIORITY JOURNAL;
RAT;
RETINA BLOOD FLOW;
RETINOPATHY;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
ALDEHYDE REDUCTASE;
ANIMALS;
BLOOD GLUCOSE;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETIC RETINOPATHY;
ENZYME INHIBITORS;
GALACTOSE;
GALACTOSEMIAS;
GUANIDINES;
MAGNETIC RESONANCE IMAGING;
NITRIC OXIDE SYNTHASE;
OXYGEN;
OXYGEN CONSUMPTION;
PARTIAL PRESSURE;
RATS;
RETINA;
RISK FACTORS;
|
EID: 0034765101
PISSN: 01460404
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (38)
|
References (26)
|